China Short Of Pediatric Drugs Because Of Poor R&D, Lack Of Clinical Subjects
This article was originally published in PharmAsia News
Executive Summary
Slightly below 2% of more than 3,500 drugs in China have pediatric dosages despite statistics that the country has a 12.9% child mortality rate